COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 382: Articles 3811-3820  | Next

Characterization of an EG.5.1 clinical isolate in vitro and in vivo
Uraki, R., Kiso, M., Iwatsuki-Horimoto, K., Yamayoshi, S., Ito, M., Chiba, S., Sakai-Tagawa, Y., Imai, M., Kashima, Y., Koga, M., Fuwa, N., Okumura, N., Hojo, M., Iwamoto, N., Kato, H., Nakajima, H., Ohmagari, N., Yotsuyanagi, H., Suzuki, Y., Kawaoka, Y.
10.1101/2023.08.31.555819 — Posted: 2023-09-01
Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine containing modified S1 spike protein of SARS-CoV-2 variant C.1.2
Bowe, M. L., Wright, E. M., Pushko, P., Backstedt, B., Gardner, C., Short-Freeman, M., Kar, S., Wright, D. C.
10.1101/2023.08.31.555805 — Posted: 2023-09-01
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53
Lee, J. D., Menasche, B. L., Mavrikaki, M., Uyemura, M. M., Hong, S. M., Kozlova, N., Wei, J., Alfajaro, M. M., Filler, R., Muller, A., Saxena, T., Posey, R. R., Cheung, P., Muranen, T., Heng, J., Paulo, J. A., Wilen, C. B., Slack, F. J.
10.1101/2023.08.31.555625 — Posted: 2023-09-01
SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection
Garvanska, D., Alvarado, R. E., Mundt, F., Nilsson, E., Duel, J., Coscia, F., Lindqvist, R., Lokugamage, K., Johnson, B., Plante, J. A., Morris, D. R., Vu, M. N., Estes, L., McLeland, A., Walker, J., Crocquet-Valdes, P., Lopez-Mendez, B., Plante, K., Walker, D. H., Weisser, M. B., Overby, A. K., Mann, M., Menachery, V. D., Nilsson, J.
10.1101/2023.09.01.555899 — Posted: 2023-09-01
Characterization of low copy number human angiotensin-convertase 2 (hACE2)-transgenic mice as an improved model of SARS-CoV-2 infection
Bradshaw, C. M., Georgieva, T., Tankersley, T. N., Taylor-Doyle, T., Johnson, L., Uhrlaub, J. L., Besselsen, D., Nikolich, J. Z.
10.1101/2023.08.31.555800 — Posted: 2023-09-01
SARS-CoV-2 Spike amyloid fibrils specifically and selectively accelerates amyloid fibril formation of human prion protein and the amyloid β peptide
Larsson, J. N., Hellstrand, E., Hammarström, P., Nyström, S.
10.1101/2023.09.01.555834 — Posted: 2023-09-01
Clinical pattern and diagnostic of comorbidity of respiratory tuberculosis and viral pneumonia caused by Herpesvirus Simplex, Human Cytomegalovirus and SARS-CoV-2 in patients with late-stage HIV infection with immunodeficiency
Mishin, V. Y., Mishina, A. V., Shashenkov, I. V.
10.1101/2023.08.30.23294716 — Posted: 2023-08-31
How much should we sequence? An analysis of the Swiss SARS- CoV-2 surveillance effort
Wegner, F., Cabrera Gil, B., Araud, T., Beckmann, C., Beerenwinkel, N., Bertelli, C., Carrara, M., Cerutti, L., Chen, C., Cordey, S., Dumoulin, A., Du Plessis, L., Friedli, M., Gerth, Y., Greub, G., Haerri, A., Hirsch, H., Howald, C., Huber, M., Imhof, A., Kaiser, L., Kufner, V., Leib, S., Leuzinger, K., Lleshi, E., Martinetti Lucchini, G., Maeusezahl, M., Moraz, M., Neher, R., Nolte, O., Ramette, A., Redondo, M., Risch, L., Rohner, L., Roloff, T., Schlaepfer, P., Schneider, K., Singer, F., Spina, V., Stadler, T., Studer, E., Topolsky, I., Trkola, A., Walther, D., Wohlwend, N., Zehnder, C., Ne
10.1101/2023.08.28.23294715 — Posted: 2023-08-31
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Ripoll Sanz, J., Tulledge-Scheitel, S., Ford, S., Pike, M., Gorman, E. K., Hanson, S. N., Juskewitch, J. E., Razonable, R. R., Ganesh, R., Hurt, R. T., Fischer, E. N., Derr, A. N., Eberle, M. R., Larsen, J. J., Carney, C. M., Theel, E. S., Parikh, S. A., Kay, N. E., Joyner, M. J., Senefeld, J.
10.1101/2023.08.29.23293790 — Posted: 2023-08-31
Vaccination status and re-infection among COVID patients admitted in COVID High Dependency Unit (HDU) of a tertiary hospital in Eastern Nepal: A cross-sectional study
Kafle, S., Chhetri, V., Bajracharya, J. L., Pokharel, L., Dawadi, S., Basnet, U., Dhungana, S., Neupane, D.
10.1101/2023.08.30.23294839 — Posted: 2023-08-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).